LIVER RISKS HIGHLIGHTED FOR REMICADE, STRATTERA
Physicians have received letters from Centocor and Eli Lilly alerting them about severe liver reactions associated with a rheumatoid arthritis product and an attention-deficit/hyperactivity disorder (ADHD) drug, according to announcements posted at the FDA’s Medwatch website.
300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.
Copyright by FDAnews. All rights reserved. Do not duplicate or redistribute in any form.